Novo Nordisk A/S | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (99)

Latest Posts

About This Stock More About This Stock
Novo Nordisk Is At The Vanguard Of The Weight Drug Revolution
Article By: GreenDotStocks
Friday, May 31, 2024 6:10 PM EDT
Novo Nordisk is based in Denmark and sells around the world. Its largest market is the U.S., at about 50% of sales.
In this article: NVO
Read
Can Weight Loss Companies Fuel Gains In Your Stock Portfolio?
Article By: Fred Fuld III
Thursday, May 9, 2024 1:32 PM EDT
Analysts predict the weight loss drug market could reach $100 billion by the end of the decade, with millions of patients potentially using these medications. However, challenges remain.
In this article: LLY, NVO, WW
Read
Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities
Article By: ChinaBio® Today
Saturday, March 23, 2024 2:00 PM EDT
Shanghai WuXi Biologics has broken ground on a $1.4 billion facility in Singapore. Meanwhile, Novo Nordisk announced plans to invest $556 million to expand its Tianjin city production facility.
In this article: MRK, NVO, BGNE, WXXWY, IVBXF, WUXIF Also: NVS, CTLT
Read
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
Article By: Zacks Investment Research
Saturday, March 9, 2024 1:40 PM EDT
This week, data from Novo Nordisk’s early-stage study on a new weight loss pill called amycretin showed that it could be more effective than Wegovy. Meanwhile, the FDA approved Johnson & Johnson's lung cancer medicine, Rybrevant, for first-line use.
In this article: AZN, JNJ, NVO, RHHBY, ALNY Also: MRK, PFE
Read
LLY Vs NVO: Which One Is Likely To Become A $1T Company First
Article By: The Tokenist
Thursday, February 8, 2024 5:06 AM EDT
Tackling growing waistlines is expected to yield much shareholder value.
In this article: LLY, NVO
Read

Latest Tweets for $NVO

No tweets yet!

PARTNER HEADLINES